Slides for the October 13, 2017 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance